Minister for Health Sussan Ley
has approved Genzyme’s Myozyme
(alglucosidase alfa) for patients over
18 with late-onset Pompe disease
through the Life Saving Drugs
Programme (LSDP) from 01 Sep.
An enzyme replacement orphan
drug, the medication has been
listed on the LSDP for children with
the infantile-onset form of the
disease since 2010 and since Feb
2015 for children aged two to 18.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.